Insider buying last 90 days
No open-market insider purchases were filed for ALB in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ALB insider filing, plotted on the chart in Gekko.Open ALB in Gekko
NYSE: ALB
Albemarle (ALB) Stock Analysis & Forecast
Sep 28 close
$107.39−2.34 (−2.1%)
Gekko Brief
AI summaryThis week's moves reflect swings in lithium pricing sentiment and diverging valuation calls rather than company-specific news. Albemarle shares fell 4.6% to $108.25 on 24 September before rising 3.4% to $116.80 and then 1.81% to $112.92 in other sessions, with commentary describing a "bearish technical trend" and "cautious outlook due to volatile lithium prices." One valuation piece pegged fair value well below current levels, while a separate feature named Albemarle among "top dividend aristocrats" on quality-adjusted fundamentals, and another contrasted it against peer FUCHS.
Albemarle last closed at $107.39, down 2.1%, sitting below both its 50-day average of $123.80 and 200-day average of $155.90, with the 50-day itself under the 200-day. The GekkoIndex reads 67.1, placing the stock in the Accumulation zone. Price stands 24.7% below the Gekko Fair Value of $142.59.
Over the next 20 trading days, the next earnings report is scheduled for 4 November, after the close, falling outside that window. Options activity shows 1 unusual signal in the last 30 days, with call premium of $550,800 and no put premium. Insider and Congressional trading data show no buy or sell counts over the last 90 days. Seasonality over 5 years shows a -0.1% average for this stretch, with gains in 3 of those years, a pattern worth noting given the stock's typical 20-day move of 10.9%.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Albemarle price vs fair value
Close $107.39200-day averageGekko Fair Value $142.59
Albemarle quick facts
- Market cap
- $12.67B
- P/E ratio
- 406.4
- Forward P/E
- 11.4
- EPS, TTM
- $0.27
- Revenue, TTM
- $5.91B
- Profit margin
- 3.8%
- Dividend yield
- 1.50%
- Beta
- 1.33
- Volume
- 2.66M avg 2.64M
- 1-year return
- +26.6%
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±10.9%
- 50-day average
- $123.80
- 200-day average
- $155.90
- Next earnings
- Nov 4 after close
- Shares outstanding
- 118.0M
Albemarle swing-trade checklist
Albemarle scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $107.39 is below the 50-day ($123.80) and 200-day ($155.90) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
67.1, Accumulation
Reading 67.1 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
24.7% below
Price is 24.7% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 30 days: 1 unusual options signal.
See smart money - Earnings risksupportive
Reports in 36 days
Next report Nov 4, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−0.1% on average
From this point in the calendar, the next 20 trading days averaged −0.1% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Albemarle stock chart and price history
Albemarle closed at $107.39 on Sep 28, 2026, +26.6% over the past year, inside a 52-week range of $79.30 to $221.00.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −20.9%
- 3 months
- −17.2%
- 6 months
- −40.2%
- 1 year
- +26.6%
The full ALB chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ALB in Gekko
Follow Albemarle through every session
Put ALB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ALB in GekkoFree for 7 days. No credit card required.
About Albemarle
Albemarle produces specialty chemicals that feed into many industrial and consumer products. Its lithium business turns out compounds like carbonate, hydroxide, and chloride, materials that go into batteries powering electric vehicles and electronic devices, plus reagents such as butyllithium used in synthesis for steroids, vitamins, and pharmaceutical work. That same business line supplies cesium for chemical and drug uses, along with zirconium, barium, and titanium destined for pyrotechnic components like airbag triggers, and it backs these products with handling guidance and recycling services for lithium waste streams.
Beyond lithium, Albemarle runs a bromine business making elemental bromine, bromide compounds, and activated carbon products applied in drilling fluids, mercury capture, water treatment, and food handling, alongside amine ingredients used in surfactants and disinfectants. A third business area, catalysts, covers agents for refining steps such as hydroprocessing, isomerization, and alkylation, plus fluid catalytic cracking materials and organometallic compounds. Together these offerings serve sectors like energy storage, refining, electronics, building materials, vehicles, lubricants, drug manufacturing, and agriculture.
The company traces back to 1887 and runs its headquarters out of Charlotte, North Carolina. Albemarle trades on the NYSE under the ticker ALB.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Website
- albemarle.com
Albemarle GekkoIndex: the smart money zone
Albemarle’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.1, in the Accumulation zone, down 0.3 points over five sessions.
67.1Accumulation
Down 0.3 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 68 | +0.2% | +0.1% | ||
| Accumulation (current zone) | 226 | −0.5% | −1.4% | ||
| Neutral | 354 | +0.8% | +2.5% | ||
| Distribution | 23 | +0.4% | +7.0% | ||
| Selling | 1 | Too few readings yet | |||
Average ALB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the ALB price, zone by zone.Track ALB in Gekko
Is Albemarle stock overvalued? Gekko Fair Value
Albemarle trades 24.7% below Gekko Fair Value of $142.59, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Albemarle shares are worth, recalculated every trading day.
$142.59
Gekko Fair Value, Sep 29, 2026
24.7% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ALB in Gekko
Albemarle insider and Congress trading
No open-market insider purchases were filed for Albemarle, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ALB were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ALB, plotted on the chart in Gekko.Open ALB in Gekko
Buybacks
Albemarle has been buying back its own shares.
- Bought back, quarter ended Mar 31, 2026
- $3.94M
- As a share of market cap
- 0.03%
From company filings.
Unusual options activity last 30 days
1signal, 100% of the flagged premium in calls.
Latest: Bullish flow on Sep 19, $551K in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold ALB.
0added0opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
Albemarle earnings: next date and track record
Albemarle reports on Nov 4, 2026, after the close (36 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Nov 4, 2026
Expected after the close, 36 days away
- EPS estimate
- $2.55
- Revenue estimate
- $1.53B
5 of 8reports beat the EPS estimate
±3.1%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 5, 2026 AI summary
- What they said
- Albemarle reported very strong Q2 2026 results driven by higher lithium pricing (energy storage) and higher pricing and volumes in Specialties. Net sales were $1.7 billion (up 31% YoY), adjusted EBITDA was $858 million (up 155% YoY) and free cash flow was $638 million. Management highlighted disciplined execution, strong cash conversion (~80% operating cash conversion), and on-track cost and productivity improvements (aiming for the high end of the $100–150M full-year target). The company raised portions of its outlook (notably specialties) while maintaining total company scenario ranges, citing stronger-than-expected stationary storage demand. Management raised its 2026 stationary storage battery production forecast to 900–1,100 GWh and increased the low end of its 2030 stationary storage range to 1,500–2,000 GWh (raising 2030 lithium demand low-end by ~100,000 tonnes). The physical lithium market is tight (low inventories), supply is lagging demand due to spodumene constraints, African shipment disruptions and slower lepidolite ramp-ups; some production restarts (e.g., Wodgina, Bald Hill) will help but not fully close the gap. Management emphasized a disciplined capital allocation approach, lower near-term capex due to capital efficiency, and progress on growth options (CGP3 ramp, potential brownfield projects, DLE permitting at Salar de Atacama).
- Guidance
- - Maintaining total company outlook ranges; management expects to be toward the high end of the $20/kg LCE scenario given H1 pricing and volume performance. - Increasing 2026 stationary storage battery production forecast to 900–1,100 GWh (up ~100 GWh vs prior forecast). - Raising low end of 2030 stationary storage forecast to 1,500–2,000 GWh; increasing low end of 2030 total lithium demand by ~100,000 tons. - Expect CGP3 ramp toward close to full production with Q1 2027 ramp timeline referenced; 2027 volume target consistent with prior 15% CAGR (implying ~240,000–260,000 t LCE by 2027). - On-track to reach high end of $100–150M FY cost/productivity improvement target. - Near-term capex reduced due to capital efficiency; management to prioritize brownfield/low-risk growth options and maintain a conservative balance sheet.
- Risks flagged
- - Supply-chain disruptions (situation in the Middle East) with an estimated ~$70–90M impact on 2026 results. - Tight physical lithium market: limited spodumene availability, temporary African shipment disruptions, slower lepidolite ramp-ups; inventories at or near record lows. - Operational incidents (e.g., CGP3 fire) that can reduce near-term volumes. - Price volatility and trader-driven market dynamics (particularly in China) that could cause unpredictable pricing moves. - Geopolitical and policy uncertainties (tax/incentive changes, government funding uncertain). - Execution risk on greenfield projects and technology (DLE) and timing of partner FIDs.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $3.75 est $3.35 | $1.74B est $1.61B | +3.8% |
| May 6, 2026 | $2.95 est $1.31 | $1.43B est $1.34B | +1.8% |
| Feb 11, 2026 | −$0.53 est −$0.42 | $1.43B est $1.35B | −5.7% |
| Nov 5, 2025 | −$0.19 est −$0.86 | $1.31B est $1.28B | +3.2% |
| Jul 30, 2025 | $0.11 est −$0.83 | $1.33B est $1.27B | −5.2% |
| Apr 30, 2025 | −$0.18 est −$0.62 | $1.08B est $1.16B | −0.2% |
| Feb 12, 2025 | −$1.09 est −$0.60 | $1.23B est $1.34B | +4.7% |
| Nov 6, 2024 | −$1.55 est −$0.44 | $1.35B est $1.37B | +0.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Albemarle stock forecast and analyst price targets
Analysts’ average 12-month price target for Albemarle is $171.56, +59.8% from the last close, from 13 firms rating the stock in the last 90 days.
$171.56consensus 12-month target, +59.8% from the last close
Now $107.39Avg $171.56
Low $140High $225
Each firm’s latest rating in the last 90 days: 13 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 23 | Mizuho Securities | $140 | +30.4% |
| Sep 11 | Jefferies | $211 | +96.5% |
| Aug 25 | J.P. Morgan | $140 | +30.4% |
| Aug 20 | DBS | $170 | +58.3% |
| Aug 10 | Morgan Stanley | $161 | +49.9% |
−1.4%average 20-day move after past Accumulation readings
−0.1%average move over the next 20 trading days in the last 5 years
±4.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Albemarle seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Albemarle averaged −0.1% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.7% | 4 of 5 |
| Next 10 trading days | +2.4% | 3 of 5 |
| Next 15 trading days | −1.0% | 2 of 5 |
| Next 20 trading days | −0.1% | 3 of 5 |
| Next 30 trading days | +7.0% | 4 of 5 |
For scale, ALB’s typical 20-trading-day move in either direction is about 10.9%.
Albemarle market cap and key statistics
Albemarle’s market cap is $12.67B, with a P/E ratio of 406.4 and revenue of $5.91B over the last twelve months.
Valuation
- Market cap
- $12.67B
- P/E ratio
- 406.4
- Forward P/E
- 11.4
- EPS, TTM
- $0.27
- Gekko Fair Value
- $142.59
Trading
- Volume
- 2.66M
- Avg volume, 20 days
- 2.64M
- 52-week high
- $221.00
- 52-week low
- $79.30
- Shares outstanding
- 118.0M
Financials
- Revenue, TTM
- $5.91B
- Profit margin
- 3.8%
- Return on equity
- 2.7%
- Quarterly earnings growth, YoY
- −66.2%
Risk and income
- Beta
- 1.33
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±10.9%
- Dividend yield
- 1.50%
Albemarle stock news this week
Coverage of Albemarle this week reads negative: 2 positive, 1 neutral and 5 negative headlines.
- Contrasting FUCHS (OTCMKTS:FUPBY) and Albemarle (NYSE:ALB)Defense World, Sep 28
- Albemarle Corp. (ALB) Stock Price Today: $108.19Pluang, Sep 28
- Top dividend aristocrats: Chevron, Emerson, and Albemarle lead on quality-adjusted fundamentalsInvesting.com, Sep 25
- Albemarle Corp. stock heads into the open after a 4.6 percent dropAD HOC NEWS, Sep 25
- Albemarle (ALB) Falls More Steeply Than Broader Market: What Investors Need to KnowYahoo Finance, Sep 25
- A Look at Albemarle Corp (ALB) After 3.4% Gain -- GF Value $80.3GuruFocus, Sep 23
Albemarle peers
Albemarle’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Accumulation | 2.8% below |
| ECLEcolab | Neutral | 8.2% above |
| APDAir Products and Chemicals | Accumulation | 11.9% below |
| DOWDow | Accumulation | 34.3% below |
| LYBLyondellBasell Industries | Accumulation | 12.3% below |
| WLKWestlake | Accumulation | 25.7% below |
A peer links to its own page where one exists.
Albemarle stock FAQ
What is Albemarle’s market cap?
Albemarle’s market cap is $12.67B at the Sep 28, 2026 close of $107.39, with 118.0M shares outstanding. The shares trade on a P/E ratio of 406.4.
What is the Albemarle stock forecast?
The consensus analyst 12-month price target for Albemarle is $171.56, +59.8% from the last close. Of the 13 firms that rated the stock in the last 90 days, 9 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Albemarle stock overvalued or undervalued?
On Gekko’s estimate Albemarle is undervalued: the Sep 28, 2026 close of $107.39 is 24.7% below Gekko Fair Value of $142.59. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Albemarle report earnings next?
Albemarle is expected to report on Nov 4, 2026, after the market closes (36 days away). Analysts expect earnings of $2.55 per share on revenue of $1.53B. Albemarle beat the earnings estimate in 5 of its last 8 reports, moving 3.1% on average across the report.
What is Albemarle’s 52-week high and low?
Albemarle’s 52-week high is $221.00 and its 52-week low is $79.30; it closed at $107.39 on Sep 28, 2026, +26.6% over the past year. Over the last five years the shares peaked at $334.55 on Nov 11, 2022.
Is Albemarle stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk), 1 as mixed (seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in Albemarle?
Gekko flagged 1 unusual options signal in Albemarle over the last 30 days, with $551K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Sep 19, 2026 with $551K in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Albemarle the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.